Oral
Aurevia
Erectile Dysfunction
Discreet, provider-directed care for intimate wellness.
- Trusted PDE5 Options
- Discreet Provider Care
- As-Needed or Daily Dosing
Starting at $60/month
Read More
Sexual Wellness & Defense
Confidential care.
Decisive treatment.
Intimate health is health. Treatment is evaluated privately, prescribed only where clinically appropriate, and reviewed alongside the rest of your clinical picture — with all medications sourced through licensed U.S. laboratories.
Protocols within this pillar
Provider-guided, personally titrated.
Oral
Aurevia
Premature Ejaculation
Daily oral therapy that may help extend ejaculatory latency.
- Faster Relief, Greater Control
- Oral & Topical Options
- Confidential Prescribing
Starting at $90 for a 3-month supply
Read More
Subcutaneous injection
Aurevia
PT-141 · Bremelanotide
Centrally acting, on-demand support for desire and arousal.
- Centrally-Acting Support
- Desire & Arousal Pathway
- Provider-Directed Dosing
Starting at $189/month
Read More
Who this is for
A pillar built for the long view.
Adults experiencing erectile difficulty
Performance changes often signal something upstream — vascular, hormonal or metabolic. Your provider treats the symptom and investigates the cause.
Patients seeking better control and timing
Premature ejaculation is common and treatable. Options are discussed candidly and prescribed where clinically appropriate.
Adults with low desire, not low function
Desire and erection are different systems. PT-141 and related options address arousal pathways where evaluation supports their use.
Anyone who wants privacy first
The entire workflow is HIPAA-secure and discreetly delivered — no waiting rooms, no counter conversations.
How provider-guided care works
One relationship, from intake onward.
01
Private intake
A confidential questionnaire captures symptoms, medications, cardiovascular history and goals.
02
Provider review
A licensed provider screens for interactions and contraindications — nitrates, cardiac history and blood pressure among them.
03
Targeted prescription
Agent, dose and timing are selected for your physiology and lifestyle, not a default script.
04
Discreet follow-up
Plain packaging, direct delivery and scheduled check-ins to refine dose or change course.
Science & evidence
Grounded in the literature.
We prescribe therapies with an established mechanism and a monitoring pathway our providers can execute reliably.
- —PDE5 inhibitors act on the nitric-oxide pathway and require sexual stimulation to work — they are enablers, not triggers.
- —Erectile dysfunction can be an early marker of endothelial and cardiovascular change, which is why history matters as much as the prescription.
- —PT-141 acts centrally on melanocortin receptors, addressing desire rather than blood flow.
- —Concurrent nitrate use is an absolute contraindication to PDE5 therapy — screening is non-negotiable.
Questions